Market Overview:
The global blood sugar lancets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in blood sugar monitoring devices, and rising demand for disposable lancets. Based on type, the global blood sugar lancets market can be segmented into disposable and non-disposable lancets. The disposable segment is expected to grow at a higher CAGR than the non-disposable segment during the forecast period. This growth can be attributed to factors such as ease of use and hygiene concerns associated with disposables. Based on application, the global blood sugar lancets market can be divided into hospitals, clinics, and others (home care settings and research laboratories). The hospitals segment is expected to account for a larger share of the global market than other segments during the forecast period.
Product Definition:
A blood sugar lancet is a small, sharp needle used to prick the skin and draw blood for testing purposes. Blood sugar lancets are typically used to test blood sugar levels in people with diabetes. Monitoring blood sugar levels is important for diabetics because it allows them to adjust their insulin dosage as needed and helps prevent dangerous spikes or drops in blood sugar levels.
Disposable:
The global disposable is expected to witness significant growth in the market owing to factors such as ease of use, safety and cost effectiveness. The major factor that propels the growth of this market is its usage in blood sugar lancets. These are used for drawing blood from animals and humans for testing glucose levels. It saves time, reduces risk and increases efficiency which ultimately increases profit margin by reducing operating costs.
Non-Disposable:
Non-disposable or sometimes called single-use lancets are used for drawing blood from patients. The most common use of these lancets is in the testing of blood sugar levels. These non-disposable devices are available in various sizes and shapes and can be reusable or disposable depending upon the type of patient, disease condition & location where it will be used.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The lancets are used for blood glucose testing in patients suffering from diabetes mellitus and other patients at risk of developing diabetes. The others application segment includes home healthcare, clinics and hospitals, etc. In clinics and hospitals, the lancets are used for self-monitoring of blood glucose (SMBG) by a patient himself/herself to regulate the diet according to dietary requirements as per the guidelines provided by a doctor or nurse during consultation room visits or hospital admissions.
Hospitals were estimated to be the fastest-growing segment with a CAGR exceeding 8% from 2018 to 2030 owing to increasing awareness about early diagnosis among governments along with rising investments by companies in R&D activities pertaining towards improving Lancet products for better results while diagnosing conditions such as diabetes at hospital level which is expected result into increased product usage across various applications over next few years.
Regional Analysis:
North America dominated the global blood sugar lancing devices market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher health expenditure levels in this region as compared to other regions. The U.S., which is one of the most developed countries regarding healthcare, accounts for a major share in North America market space.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving economic conditions and increasing prevalence of diabetes among people especially in India and China as a result of changing lifestyles along with an increase in urbanization rate has led to an overall rise in metabolic disorders including diabetes that requires proper diagnosis and treatment at early stages through access provided by ambulatory medical services (AMS). Such factors are expected favorably impact demand for lancing devices globally during the forecast period thereby leading to increased revenue shares for Asia Pacific regional market space over other regions’ markets spaces during same time frame.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for blood sugar lancets in the coming years.
- Technological advancements: The development of new and innovative technologies has led to the introduction of advanced blood sugar lancets in the market. This is likely to boost the growth of this market in the near future.
- Rising awareness about diabetes: There is a growing awareness about diabetes among people across the globe, which is likely to increase demand for blood sugar lancets in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Sugar Lancets Market Research Report
By Type
Disposable, Non-Disposable
By Application
Hospitals, Clinics, Others
By Companies
Bayer, Roche, AgaMatrix, Nova Biomedical, Integrity Applications, Medisana, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Blood Sugar Lancets Market Report Segments:
The global Blood Sugar Lancets market is segmented on the basis of:
Types
Disposable, Non-Disposable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Roche
- AgaMatrix
- Nova Biomedical
- Integrity Applications
- Medisana
- Bayer
Highlights of The Blood Sugar Lancets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Disposable
- Non-Disposable
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Sugar Lancets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A blood sugar lancet is a small, thin device used to measure blood sugar levels.
Some of the major players in the blood sugar lancets market are Bayer, Roche, AgaMatrix, Nova Biomedical, Integrity Applications, Medisana, Bayer.
The blood sugar lancets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Sugar Lancets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Sugar Lancets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Sugar Lancets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Sugar Lancets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Sugar Lancets Market Size & Forecast, 2018-2028
4.5.1 Blood Sugar Lancets Market Size and Y-o-Y Growth
4.5.2 Blood Sugar Lancets Market Absolute $ Opportunity
Chapter 5 Global Blood Sugar Lancets Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Sugar Lancets Market Size Forecast by Type
5.2.1 Disposable
5.2.2 Non-Disposable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Sugar Lancets Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Sugar Lancets Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Sugar Lancets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Sugar Lancets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Sugar Lancets Analysis and Forecast
9.1 Introduction
9.2 North America Blood Sugar Lancets Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Sugar Lancets Market Size Forecast by Type
9.6.1 Disposable
9.6.2 Non-Disposable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Sugar Lancets Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Sugar Lancets Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Sugar Lancets Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Sugar Lancets Market Size Forecast by Type
10.6.1 Disposable
10.6.2 Non-Disposable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Sugar Lancets Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Sugar Lancets Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Sugar Lancets Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Sugar Lancets Market Size Forecast by Type
11.6.1 Disposable
11.6.2 Non-Disposable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Sugar Lancets Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Sugar Lancets Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Sugar Lancets Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Sugar Lancets Market Size Forecast by Type
12.6.1 Disposable
12.6.2 Non-Disposable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Sugar Lancets Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Sugar Lancets Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Sugar Lancets Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Sugar Lancets Market Size Forecast by Type
13.6.1 Disposable
13.6.2 Non-Disposable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Sugar Lancets Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Sugar Lancets Market: Competitive Dashboard
14.2 Global Blood Sugar Lancets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Roche
14.3.3 AgaMatrix
14.3.4 Nova Biomedical
14.3.5 Integrity Applications
14.3.6 Medisana
14.3.7 Bayer
